BAK1P2

Across TCGA pan-cancer cohorts, BAK1P2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated BAK1P2 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher BAK1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BAK1P2 expression acts as an unfavorable survival marker, although some lineages such as BRCA and ESCA show a favorable association.

LUSC, UCEC, and STAD are the cancer types where BAK1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	36	view →
UCEC	DFS	Median	All	0.786	0.867	.004	32	view →
STAD	DFS	Quartile	III,IV	0.456	0.638	.008	31	view →
BRCA	OS	Median	II,III,IV	0.662	0.481	.004	26	view →
LUAD	OS	Tertile	All	0.203	0.390	.014	24	view →
CESC	OS	Tertile	III,IV	0.453	0.786	.014	24	view →
LAML	DFS	Median	All	0.233	0.514	.018	24	view →
ESCA	DFS	Tertile	III,IV	0.549	0.245	.006	17	view →
UCS	DFS	Tertile	All	0.373	0.598	.028	16	view →
KIRP	DFS	Median	All	0.333	0.698	<.001	15	view →
LIHC	OS	Tertile	II,III,IV	0.128	0.623	.010	15	view →
UVM	OS	Tertile	All	0.400	0.706	.037	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

BAK1P2–LUSC (DFS)

Open the LUSC breakdown →